














DEVELOPMENT OF HIGH-THROUGHPUT CARDIOTOXICITY TEST USING MULTI-ELECTRODE SYSTEM. 
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As drugs always have side effects, toxicity testing is indispensable at the preclinical testing. In particular, 
cardiotoxicity testing is important because cardiotoxicity induces lethal arrhythmias. The toxicity test takes a 
huge amount of time and cost, and a method that further improves cost, ethics, and technical aspects are 
required. We constructed a noninvasive and high-throughput cardiotoxicity testing system that could obtain the 
signals of 64 cardiomyocyte populations at 1-time measurement. However, the signal was small and 
inappropriate for cardiotoxicity testing. Therefore, a chamber that forms a large cell population was created to 
increase the signal. As a result, we successfully obtained a signal that can be used for toxicity testing. 
















多電極電位計測 (Multi Electrode Array: MEA) システ


















1 辺 350 µm 程度の Large chamber と直径 100 µm 程度の
Small chamber の２つのパターンを作製した。 
 
 






て 37℃・5％CO2条件下にてインキュベーター内で 5 日間
培養した。心筋細胞の拍動に伴う細胞外電位変化に関し







(Fig. 2)。1 つ目は Na+ピークから次の Na+ピークまでの
時間差を測定する拍動間隔  (Interspike Interval: 
ISI) 、2 つ目は Na+ピークから K+ピークまでの時間差を
測定した電位持続時間 (Field Potential Duration: 












chamber と Small chamber を交互に配置したチャンバー
上に心筋細胞を播種して培養と測定を行った。拍動が安
定する培養 2、3 日目の時点での波形の振幅を測定した結
果、Large chamber は Small chamber のおよそ 3 倍の振
幅であった (Fig. 3)。 
 
 





ISI と FPD の培養日数毎の取得率を測定した (Fig. 4)。

























1. Waldman SA., Clinical Pharmacology & Therapeutics. 
2012; 91(3): 353-7. 
 
2. Yamamoto W., et al., PLoS One. 2016; 11(12): e0167348. 
 
3. Asakura K., et al., Journal of Pharmacological and 
Toxicological Methods. 2015; 75: 17-26. 
 
4. Mordwinkin N., et al., J. of Cardiovasc. Trans. Res. 2013; 
6(1): 22-30. 
